Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4102948
Max Phase: Preclinical
Molecular Formula: C26H31FN4O4S
Molecular Weight: 514.62
Molecule Type: Small molecule
Associated Items:
ID: ALA4102948
Max Phase: Preclinical
Molecular Formula: C26H31FN4O4S
Molecular Weight: 514.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccccc1S(=O)(=O)N1CCN(c2ccc(C(CO)(CO)CCc3ccc(F)cc3)nn2)CC1
Standard InChI: InChI=1S/C26H31FN4O4S/c1-20-4-2-3-5-23(20)36(34,35)31-16-14-30(15-17-31)25-11-10-24(28-29-25)26(18-32,19-33)13-12-21-6-8-22(27)9-7-21/h2-11,32-33H,12-19H2,1H3
Standard InChI Key: QNHLQADNAGBWKW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 514.62 | Molecular Weight (Monoisotopic): 514.2050 | AlogP: 2.29 | #Rotatable Bonds: 9 |
Polar Surface Area: 106.86 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.48 | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.45 | Np Likeness Score: -1.62 |
1. Llona-Minguez S, Höglund A, Ghassemian A, Desroses M, Calderón-Montaño JM, Burgos Morón E, Valerie NCK, Wiita E, Almlöf I, Koolmeister T, Mateus A, Cazares-Körner C, Sanjiv K, Homan E, Loseva O, Baranczewski P, Darabi M, Mehdizadeh A, Fayezi S, Jemth AS, Warpman Berglund U, Sigmundsson K, Lundbäck T, Jenmalm Jensen A, Artursson P, Scobie M, Helleday T.. (2017) Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors., 60 (10): [PMID:28508636] [10.1021/acs.jmedchem.7b00182] |
Source(1):